Yahoo
Brussels - Delayed Quote EUR

Care Property Invest NV (CPINV.BR)

12.30 -0.10 (-0.81%)
At close: October 30 at 5:35:04 PM GMT+1
Chart Range Bar
Loading chart for CPINV.BR
  • Previous Close 12.40
  • Open 12.40
  • Bid --
  • Ask --
  • Day's Range 12.26 - 12.42
  • 52 Week Range 10.70 - 14.04
  • Volume 14,598
  • Avg. Volume 43,790
  • Market Cap (intraday) 519.957M
  • Beta (5Y Monthly) 0.58
  • PE Ratio (TTM) 7.83
  • EPS (TTM) 1.57
  • Earnings Date Nov 4, 2026
  • Forward Dividend & Yield 1.00 (8.13%)
  • Ex-Dividend Date May 29, 2026
  • 1y Target Est 13.22

Care Property Invest NV is a Public Regulated Real Estate Company under Belgian law. The Company has been listed on Euronext Brussels for 30 years and invests in high quality healthcare real estate for elderly and disabled people on the European market. Care Property Invest purchases, builds and renovates high quality healthcare real estate, fully tailored to the needs of the end user and then makes it available to solid healthcare operators on the basis of a long-term contract. The Company is developing an international portfolio of healthcare projects, which currently counts 160 projects, spread across Belgium, The Netherlands, Spain and Ireland. The market capitalisation of Care Property Invest amounted to approximately 514 million euro on 12/08/2026. The Company aims to create a stable share for its shareholders with a low risk profile and a stable and steadily growing dividend. Care Property Invest NV was established in 1995 and was incorporated in Belgium.

carepropertyinvest.be

22

Full Time Employees

December 31

Fiscal Year Ends

Real Estate

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is BEL 20 (^BFX) .

YTD Return

CPINV.BR
5.39%
BEL 20 (^BFX)
15.03%

1-Year Return

CPINV.BR
16.95%
BEL 20 (^BFX)
17.47%

3-Year Return

CPINV.BR
35.65%
BEL 20 (^BFX)
77.50%

5-Year Return

CPINV.BR
31.76%
BEL 20 (^BFX)
36.52%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY21
Revenue 31.8M
Earnings --
Profit Margin 0.00%

Q3

FY15

Q1

FY17

Q1

FY21

Q3

FY21

0
10M
20M
30M
0.0%

Analyst Insights

View More

Analyst Price Targets

10.50 Low
13.22 Average
12.30 Current
16.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    77.44%

  • Return on Assets (ttm)

    3.14%

  • Return on Equity (ttm)

    9.44%

  • Revenue (ttm)

    79.57M

  • Net Income Avi to Common (ttm)

    61.62M

  • Diluted EPS (ttm)

    1.57

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.28M

  • Total Debt/Equity (mrq)

    99.40%

  • Levered Free Cash Flow (ttm)

    15.65M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: